Stoke Therapeutics (STOK) Equity Ratio (2022 - 2025)
Stoke Therapeutics has reported Equity Ratio over the past 4 years, most recently at 0.84 for Q4 2025.
- Quarterly results put Equity Ratio at 0.84 for Q4 2025, changed 0.12% from a year ago — trailing twelve months through Dec 2025 was 0.84 (changed 0.12% YoY), and the annual figure for FY2025 was 0.84, changed 0.12%.
- Equity Ratio for Q4 2025 was 0.84 at Stoke Therapeutics, down from 0.86 in the prior quarter.
- Over the last five years, Equity Ratio for STOK hit a ceiling of 0.87 in Q2 2025 and a floor of 0.68 in Q1 2024.
- Median Equity Ratio over the past 4 years was 0.76 (2022), compared with a mean of 0.78.
- Biggest five-year swings in Equity Ratio: dropped 9.86% in 2024 and later increased 25.79% in 2025.
- Stoke Therapeutics' Equity Ratio stood at 0.72 in 2022, then fell by 3.2% to 0.7 in 2023, then rose by 20.69% to 0.84 in 2024, then fell by 0.12% to 0.84 in 2025.
- The last three reported values for Equity Ratio were 0.84 (Q4 2025), 0.86 (Q3 2025), and 0.87 (Q2 2025) per Business Quant data.